Author:
Ocker Matthias,Alajati Abdullah,Ganslmayer Marion,Zopf Steffen,L�ders Mike,Neureiter Daniel,Hahn Eckhart G.,Schuppan Detlef,Herold Christoph
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine
Reference33 articles.
1. Benson AB III, Mitchel E, Abramson N, Klencke B, Ritch P, Burnham JP, McGuirt C, Bonny T, Levin J, Hohneker J (2002) Oral eniluracil/5-fluorouracil in patients with inoperable hepatocellular carcinoma. Ann Oncol 13:576?581
2. Butler LM, Agus DB, Scher HI, Higgins B, Rose A, Cordon-Cardo C, Thaler HT, Rifkind RA, Marks PA, Richon VM (2000) Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, suppresses the growth of prostate cancer cells in vitro and in vivo. Cancer Res 60:5165?5170
3. Butler LM, Zhou X, Xu WS, Scher HI, Rifkind RA, Marks PA, Richon VM (2002) The histone deacetylase inhibitor SAHA arrests cancer cell growth, up-regulates thioredoxin-binding protein-2, and down-regulates thioredoxin. Proc Natl Acad Sci U S A 99:11700?11705
4. Cance WG, Stewart AK, Menck HR (2000) The national cancer data base report on treatment patterns for hepatocellular carcinoma. Cancer 88:912?920
5. Cao S, Rustum YM (2000) Synergistic antitumor activity of irinotecan in combination with 5-fluorouracil in rats bearing advanced colorectal cancer: role of drug sequence and dose. Cancer Res 60:3717?3721
Cited by
66 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献